Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin L Jones

Showing results (1-10 of 393) with videos related to

Pageof 40
Sort By:
Expert Review of Cardiovascular Therapy|November 21, 2008
Utility of dexrazoxane for the reduction of anthracycline-induced cardiotoxicityRobin L Jones
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2014
Success is not final and failure is not fatalRobin L Jones
Future Oncology (London, England)|September 11, 2019
Sarcomas and old age: few options for such a large patient populationRobin L Jones
The New England Journal of Medicine|September 28, 2018
Trends in Modern Phase 1 Oncology TrialsRobin L Jones
Future Oncology (London, England)|December 8, 2016
Understanding sarcomas and other rare tumors: an interview with Robin L JonesRobin L Jones
Future Oncology (London, England)|October 3, 2022
On the road to improved outcomes by capturing leiomyosarcoma patients' viewsRobin L Jones
Translational Gastroenterology and Hepatology|May 22, 2018
Perspectives on the evolving state of the art management of gastrointestinal stromal tumoursZoltan Szucs, Robin L Jones
Clinical Colorectal Cancer|March 7, 2003
Clinical and molecular prognostic factors in patients with metastatic colorectal cancer treated with 5-fluorouracil-based chemotherapyRobin L Jones, David Cunningham
International Journal of Clinical Oncology|February 8, 2012
The efficacy of caffeine-potentiated chemotherapy in clear cell sarcomaRobin L Jones, Anastasia Constantinidou
Nature Reviews. Clinical Oncology|August 9, 2017
Sarcoma: Does histotype-tailored neoadjuvant therapy improve outcomes?Robin L Jones, Khin Thway
Pageof 40

Showing results (1-10 of 393) with videos related to

Sort By:
Pageof 40
Expert Review of Cardiovascular Therapy|November 21, 2008
Utility of dexrazoxane for the reduction of anthracycline-induced cardiotoxicityRobin L Jones
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2014
Success is not final and failure is not fatalRobin L Jones
Future Oncology (London, England)|September 11, 2019
Sarcomas and old age: few options for such a large patient populationRobin L Jones
The New England Journal of Medicine|September 28, 2018
Trends in Modern Phase 1 Oncology TrialsRobin L Jones
Future Oncology (London, England)|December 8, 2016
Understanding sarcomas and other rare tumors: an interview with Robin L JonesRobin L Jones
Future Oncology (London, England)|October 3, 2022
On the road to improved outcomes by capturing leiomyosarcoma patients' viewsRobin L Jones
Translational Gastroenterology and Hepatology|May 22, 2018
Perspectives on the evolving state of the art management of gastrointestinal stromal tumoursZoltan Szucs, Robin L Jones
Clinical Colorectal Cancer|March 7, 2003
Clinical and molecular prognostic factors in patients with metastatic colorectal cancer treated with 5-fluorouracil-based chemotherapyRobin L Jones, David Cunningham
International Journal of Clinical Oncology|February 8, 2012
The efficacy of caffeine-potentiated chemotherapy in clear cell sarcomaRobin L Jones, Anastasia Constantinidou
Nature Reviews. Clinical Oncology|August 9, 2017
Sarcoma: Does histotype-tailored neoadjuvant therapy improve outcomes?Robin L Jones, Khin Thway
Pageof 40